 | • レポートコード：MRC2-11QY03990 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は夜間頻尿のグローバル市場について調査・分析したレポートです。種類別（抗コリン薬、デスモプレシン、抗生物質、鎮痙薬、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別夜間頻尿の競争状況、市場シェア ・世界の夜間頻尿市場：種類別市場規模 2015年-2020年（抗コリン薬、デスモプレシン、抗生物質、鎮痙薬、その他） ・世界の夜間頻尿市場：種類別市場規模予測 2021年-2026年（抗コリン薬、デスモプレシン、抗生物質、鎮痙薬、その他） ・世界の夜間頻尿市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界の夜間頻尿市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米の夜間頻尿市場分析：米国、カナダ ・ヨーロッパの夜間頻尿市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの夜間頻尿市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の夜間頻尿市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの夜間頻尿市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Allergan、Urigen Pharmaceuticals、Ferring Pharmaceuticals、Glenmark Pharmaceuticals、Teva Pharmaceutical Industries、AA Pharma、Avadel Pharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Nocturia, also called nycturia (Greek νυκτουρία), is defined by the International Continence Society (ICS) as “the complaint that the individual has to wake at night one or more times for voiding (i.e. to urinate).” Its causes are varied and, in many patients, difficult to discern.
Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period.
Market Analysis and Insights: Global Nocturia Market
The global Nocturia market size is projected to reach US$ 2182.2 million by 2026, from US$ 2039.4 million in 2020, at a CAGR of 6.5%% during 2021-2026.
Global Nocturia Scope and Market Size
Nocturia market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Nocturia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Allergan
Urigen Pharmaceuticals
Ferring Pharmaceuticals
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries
AA Pharma
Avadel Pharmaceuticals
…
Market segment by Type, the product can be split into
Anticholinergic Drugs
Desmopressin
Antibiotics
Antispasmodic
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nocturia Revenue
1.4 Market by Type
1.4.1 Global Nocturia Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Anticholinergic Drugs
1.4.3 Desmopressin
1.4.4 Antibiotics
1.4.5 Antispasmodic
1.4.6 Others
1.5 Market by Application
1.5.1 Global Nocturia Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Nocturia Market Perspective (2015-2026)
2.2 Global Nocturia Growth Trends by Regions
2.2.1 Nocturia Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Nocturia Historic Market Share by Regions (2015-2020)
2.2.3 Nocturia Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Nocturia Market Growth Strategy
2.3.6 Primary Interviews with Key Nocturia Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Nocturia Players by Market Size
3.1.1 Global Top Nocturia Players by Revenue (2015-2020)
3.1.2 Global Nocturia Revenue Market Share by Players (2015-2020)
3.1.3 Global Nocturia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nocturia Market Concentration Ratio
3.2.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2019
3.3 Nocturia Key Players Head office and Area Served
3.4 Key Players Nocturia Product Solution and Service
3.5 Date of Enter into Nocturia Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Nocturia Historic Market Size by Type (2015-2020)
4.2 Global Nocturia Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Nocturia Market Size by Application (2015-2020)
5.2 Global Nocturia Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Nocturia Market Size (2015-2020)
6.2 Nocturia Key Players in North America (2019-2020)
6.3 North America Nocturia Market Size by Type (2015-2020)
6.4 North America Nocturia Market Size by Application (2015-2020)
7 Europe
7.1 Europe Nocturia Market Size (2015-2020)
7.2 Nocturia Key Players in Europe (2019-2020)
7.3 Europe Nocturia Market Size by Type (2015-2020)
7.4 Europe Nocturia Market Size by Application (2015-2020)
8 China
8.1 China Nocturia Market Size (2015-2020)
8.2 Nocturia Key Players in China (2019-2020)
8.3 China Nocturia Market Size by Type (2015-2020)
8.4 China Nocturia Market Size by Application (2015-2020)
9 Japan
9.1 Japan Nocturia Market Size (2015-2020)
9.2 Nocturia Key Players in Japan (2019-2020)
9.3 Japan Nocturia Market Size by Type (2015-2020)
9.4 Japan Nocturia Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Nocturia Market Size (2015-2020)
10.2 Nocturia Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nocturia Market Size by Type (2015-2020)
10.4 Southeast Asia Nocturia Market Size by Application (2015-2020)
11 India
11.1 India Nocturia Market Size (2015-2020)
11.2 Nocturia Key Players in India (2019-2020)
11.3 India Nocturia Market Size by Type (2015-2020)
11.4 India Nocturia Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Nocturia Market Size (2015-2020)
12.2 Nocturia Key Players in Central & South America (2019-2020)
12.3 Central & South America Nocturia Market Size by Type (2015-2020)
12.4 Central & South America Nocturia Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Allergan
13.1.1 Allergan Company Details
13.1.2 Allergan Business Overview
13.1.3 Allergan Nocturia Introduction
13.1.4 Allergan Revenue in Nocturia Business (2015-2020))
13.1.5 Allergan Recent Development
13.2 Urigen Pharmaceuticals
13.2.1 Urigen Pharmaceuticals Company Details
13.2.2 Urigen Pharmaceuticals Business Overview
13.2.3 Urigen Pharmaceuticals Nocturia Introduction
13.2.4 Urigen Pharmaceuticals Revenue in Nocturia Business (2015-2020)
13.2.5 Urigen Pharmaceuticals Recent Development
13.3 Ferring Pharmaceuticals
13.3.1 Ferring Pharmaceuticals Company Details
13.3.2 Ferring Pharmaceuticals Business Overview
13.3.3 Ferring Pharmaceuticals Nocturia Introduction
13.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2015-2020)
13.3.5 Ferring Pharmaceuticals Recent Development
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Details
13.4.2 Glenmark Pharmaceuticals Business Overview
13.4.3 Glenmark Pharmaceuticals Nocturia Introduction
13.4.4 Glenmark Pharmaceuticals Revenue in Nocturia Business (2015-2020)
13.4.5 Glenmark Pharmaceuticals Recent Development
13.5 Teva Pharmaceutical Industries
13.5.1 Teva Pharmaceutical Industries Company Details
13.5.2 Teva Pharmaceutical Industries Business Overview
13.5.3 Teva Pharmaceutical Industries Nocturia Introduction
13.5.4 Teva Pharmaceutical Industries Revenue in Nocturia Business (2015-2020)
13.5.5 Teva Pharmaceutical Industries Recent Development
13.6 AA Pharma
13.6.1 AA Pharma Company Details
13.6.2 AA Pharma Business Overview
13.6.3 AA Pharma Nocturia Introduction
13.6.4 AA Pharma Revenue in Nocturia Business (2015-2020)
13.6.5 AA Pharma Recent Development
13.7 Avadel Pharmaceuticals
13.7.1 Avadel Pharmaceuticals Company Details
13.7.2 Avadel Pharmaceuticals Business Overview
13.7.3 Avadel Pharmaceuticals Nocturia Introduction
13.7.4 Avadel Pharmaceuticals Revenue in Nocturia Business (2015-2020)
13.7.5 Avadel Pharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Nocturia Key Market Segments
Table 2. Key Players Covered: Ranking by Nocturia Revenue
Table 3. Ranking of Global Top Nocturia Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nocturia Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Anticholinergic Drugs
Table 6. Key Players of Desmopressin
Table 7. Key Players of Antibiotics
Table 8. Key Players of Antispasmodic
Table 9. Key Players of Others
Table 10. Global Nocturia Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Nocturia Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Nocturia Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Nocturia Market Share by Regions (2015-2020)
Table 14. Global Nocturia Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Nocturia Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Nocturia Market Growth Strategy
Table 20. Main Points Interviewed from Key Nocturia Players
Table 21. Global Nocturia Revenue by Players (2015-2020) (Million US$)
Table 22. Global Nocturia Market Share by Players (2015-2020)
Table 23. Global Top Nocturia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturia as of 2019)
Table 24. Global Nocturia by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Nocturia Product Solution and Service
Table 27. Date of Enter into Nocturia Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Nocturia Market Size by Type (2015-2020) (Million US$)
Table 30. Global Nocturia Market Size Share by Type (2015-2020)
Table 31. Global Nocturia Revenue Market Share by Type (2021-2026)
Table 32. Global Nocturia Market Size Share by Application (2015-2020)
Table 33. Global Nocturia Market Size by Application (2015-2020) (Million US$)
Table 34. Global Nocturia Market Size Share by Application (2021-2026)
Table 35. North America Key Players Nocturia Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Nocturia Market Share (2019-2020)
Table 37. North America Nocturia Market Size by Type (2015-2020) (Million US$)
Table 38. North America Nocturia Market Share by Type (2015-2020)
Table 39. North America Nocturia Market Size by Application (2015-2020) (Million US$)
Table 40. North America Nocturia Market Share by Application (2015-2020)
Table 41. Europe Key Players Nocturia Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Nocturia Market Share (2019-2020)
Table 43. Europe Nocturia Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Nocturia Market Share by Type (2015-2020)
Table 45. Europe Nocturia Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Nocturia Market Share by Application (2015-2020)
Table 47. China Key Players Nocturia Revenue (2019-2020) (Million US$)
Table 48. China Key Players Nocturia Market Share (2019-2020)
Table 49. China Nocturia Market Size by Type (2015-2020) (Million US$)
Table 50. China Nocturia Market Share by Type (2015-2020)
Table 51. China Nocturia Market Size by Application (2015-2020) (Million US$)
Table 52. China Nocturia Market Share by Application (2015-2020)
Table 53. Japan Key Players Nocturia Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Nocturia Market Share (2019-2020)
Table 55. Japan Nocturia Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Nocturia Market Share by Type (2015-2020)
Table 57. Japan Nocturia Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Nocturia Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Nocturia Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Nocturia Market Share (2019-2020)
Table 61. Southeast Asia Nocturia Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Nocturia Market Share by Type (2015-2020)
Table 63. Southeast Asia Nocturia Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Nocturia Market Share by Application (2015-2020)
Table 65. India Key Players Nocturia Revenue (2019-2020) (Million US$)
Table 66. India Key Players Nocturia Market Share (2019-2020)
Table 67. India Nocturia Market Size by Type (2015-2020) (Million US$)
Table 68. India Nocturia Market Share by Type (2015-2020)
Table 69. India Nocturia Market Size by Application (2015-2020) (Million US$)
Table 70. India Nocturia Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Nocturia Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Nocturia Market Share (2019-2020)
Table 73. Central & South America Nocturia Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Nocturia Market Share by Type (2015-2020)
Table 75. Central & South America Nocturia Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Nocturia Market Share by Application (2015-2020)
Table 77. Allergan Company Details
Table 78. Allergan Business Overview
Table 79. Allergan Product
Table 80. Allergan Revenue in Nocturia Business (2015-2020) (Million US$)
Table 81. Allergan Recent Development
Table 82. Urigen Pharmaceuticals Company Details
Table 83. Urigen Pharmaceuticals Business Overview
Table 84. Urigen Pharmaceuticals Product
Table 85. Urigen Pharmaceuticals Revenue in Nocturia Business (2015-2020) (Million US$)
Table 86. Urigen Pharmaceuticals Recent Development
Table 87. Ferring Pharmaceuticals Company Details
Table 88. Ferring Pharmaceuticals Business Overview
Table 89. Ferring Pharmaceuticals Product
Table 90. Ferring Pharmaceuticals Revenue in Nocturia Business (2015-2020) (Million US$)
Table 91. Ferring Pharmaceuticals Recent Development
Table 92. Glenmark Pharmaceuticals Company Details
Table 93. Glenmark Pharmaceuticals Business Overview
Table 94. Glenmark Pharmaceuticals Product
Table 95. Glenmark Pharmaceuticals Revenue in Nocturia Business (2015-2020) (Million US$)
Table 96. Glenmark Pharmaceuticals Recent Development
Table 97. Teva Pharmaceutical Industries Company Details
Table 98. Teva Pharmaceutical Industries Business Overview
Table 99. Teva Pharmaceutical Industries Product
Table 100. Teva Pharmaceutical Industries Revenue in Nocturia Business (2015-2020) (Million US$)
Table 101. Teva Pharmaceutical Industries Recent Development
Table 102. AA Pharma Company Details
Table 103. AA Pharma Business Overview
Table 104. AA Pharma Product
Table 105. AA Pharma Revenue in Nocturia Business (2015-2020) (Million US$)
Table 106. AA Pharma Recent Development
Table 107. Avadel Pharmaceuticals Company Details
Table 108. Avadel Pharmaceuticals Business Overview
Table 109. Avadel Pharmaceuticals Product
Table 110. Avadel Pharmaceuticals Revenue in Nocturia Business (2015-2020) (Million US$)
Table 111. Avadel Pharmaceuticals Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nocturia Market Share by Type: 2020 VS 2026
Figure 2. Anticholinergic Drugs Features
Figure 3. Desmopressin Features
Figure 4. Antibiotics Features
Figure 5. Antispasmodic Features
Figure 6. Others Features
Figure 7. Global Nocturia Market Share by Application: 2020 VS 2026
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Nocturia Report Years Considered
Figure 12. Global Nocturia Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Nocturia Market Share by Regions: 2020 VS 2026
Figure 14. Global Nocturia Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Nocturia Market Share by Players in 2019
Figure 17. Global Top Nocturia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturia as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2019
Figure 19. North America Nocturia Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Nocturia Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Nocturia Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Nocturia Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Nocturia Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Nocturia Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Nocturia Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
バーター症候群治療薬の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% d…- 植物・植物由来薬剤の世界市場（～2026年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- OTC外用薬の世界市場（～2026年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…